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ABSTRACT  
Objective: Bipolar disorder (BD) is one of the most heritable psychiatric conditions and is 
associated with high suicide risks. To explore the reasons for this link, we examine the 
interaction between traumatic stress and BD polygenic risk score in relation to suicidal ideation, 
suicide attempt and non-suicidal self-injury (NSSI) among adolescent/young adult offspring and 
relatives of persons with BD (“BD-relatives”) and adolescent/young adult offspring of 
individuals without psychiatric disorders (“controls”).  
Method: Data were collected from four sites in the US and one in Australia during 2006-2012. 
Generalized estimating equation models were used to compare rates of ideation, attempts, and 
NSSI between BD-relatives (n=307) and controls (n=166), while also studying the contribution 
of demographic factors, traumatic stress exposure, lifetime mood or substance (alcohol/drug) use 
disorders, and BD polygenic risk score.  
Results: After adjusting for demographic characteristics and mood and substance use disorders, 
BD-relatives were at increased risk for ideation and attempts, but not NSSI. Independent of BD-
relative/control status, demographic factors, mood and substance use disorders, exposure to 
trauma within the past year (including bullying, sexual abuse, and domestic violence) was 
associated with suicide attempt (p=.014), and BD polygenic risk score was also marginally 
associated with attempts (.061). Importantly, the interaction between BD polygenic risk score 
and traumatic event exposures was significantly associated with attempts, independent of 
demographics, relative/control status, and mood and substance use disorders (p=.037).  
Conclusion: BD-relatives are at increased risk for suicide attempts and ideation, especially if 
they are exposed to trauma and have evidence of increased genetic vulnerability. 
Key words: bipolar disorder; suicide, attempted; populations at risk; polygenic risk; traumatic 
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stress 
INTRODUCTION 
Individuals with bipolar disorder (BD) are at high risk for suicide attempts and suicide 
death.1 As many as 20-25% of individuals with a clinical diagnosis of BD die by suicide.2,3 A 
systematic review by Tondo4 reported that in 101 published studies from 22 countries 
(N=80,000), 31% of those with BD made at least one lifetime suicide attempt, versus 4% of 
community-residing adults. Simon et al.5 noted the relatively low suicide attempt to suicide death 
ratio within persons with BD as compared to the general population, which suggests stronger 
suicide intent and higher lethality of methods.  
Although an earlier onset of BD is associated with increased risk of suicidal behaviors,6 
ideation and attempts remain significantly under-researched in adolescents and young adults at 
high familial risk for BD, particularly in genetically informative samples with prospective 
longitudinal designs. Two studies of youth at risk for BD have reported elevated rates of ideation 
and attempts. Klimes-Dougan7 found that BD offspring at the average age of 22 years were at 
higher risk for suicide plans and attempts than offspring of parents with major depressive 
disorder (MDD) and offspring of well parents; however, that study had a small sample size of 37 
BD offspring. Goldstein,8 using data from the Pittsburgh Bipolar Offspring Study (BIOS)9 of 388 
offspring (ages 6-18 years) of 233 parents with bipolar I (BP-I) or bipolar II (BP-II) as well as 
250 offspring of matched control parents, found that BD offspring had significantly elevated 
rates of ideation (33% vs. 20%; OR=2.1).  
Studies have found that as many as 50% of adults with BD report a history of childhood 
abuse,10-14 and many studies report that adults with BD who experienced child physical or sexual 
abuse were younger at BD symptom onset and experienced a worse clinical course compared to 
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those without abuse.10-12, 15 In a systematic review of childhood maltreatment in BD, Agnew-
Blais and Danese16 found that maltreatment was associated with several negative clinical 
outcomes, including suicide attempts, and might be an early indicator of a particularly 
unfavorable clinical course.  
The stress–diathesis model of suicidal behavior17 describes suicidal behaviors to be the 
result of an interaction between state-dependent stressors and a trait-like susceptibility to suicidal 
behavior that includes both familial and genetic factors. Indeed, offspring of parents with BD 
may have biological vulnerabilities that increase their risk for depression and suicide,18 but may 
also experience disruptive home environments including exposure to parental suicidal 
behaviors.19,20  
A number of studies have attempted to map specific genetic variants underlying suicidal 
behaviors, using approaches both within and across psychiatric diagnoses, so far with limited 
success (reviewed in Sokolowski21). This is largely due to the relatively small sample sizes 
hitherto examined (typically <5,000 individuals with suicide attempt data). However, as with the 
genetic architecture of psychiatric diagnoses,22,23 susceptibility to ideation and attempt appears to 
be highly polygenic.24-26 In one of the larger genome-wide association studies (GWAS) to date, 
Willour et al.24 examined 1,200 individuals with BD who had attempted suicide and 1,497 BD 
non-attempters, finding no single nucleotide polymorphisms (SNPs) exceeding genome-wide 
significance for association. However, of 2,507 SNPs with p<.001 in the primary study, 49 
replicated to p<.01 with the same direction of effect in an independent cohort of 1,295 attempters 
with BD and 1,822 non-attempters with BD.24 It is unclear as to the genetic overlap between risk 
genes for psychiatric disorders and suicide attempts, although preliminary studies in small 
samples suggest partial pleiotropy.25 Polygenic risk scores derived from the sum of individual 
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effects of many hundreds of BD-associated variants may help elucidate the relative contributions 
of genes versus environment for suicidal behaviors in BD.  
Herein we examine ideation, attempts, and non-suicidal self-injury (NSSI) in 307 
adolescent offspring/relatives of parents affected with BD (BD-relatives) as compared to 166 
offspring/relatives of parents without specific psychiatric disorders (controls). The aims of the 
study were to assess whether: 1) BD-relatives are at greater risk of suicidal/self-harm behaviors 
than controls, independent of a personal history of mood or substance use disorders; 2) whether 
an individual’s genetic risk for BD (i.e., polygenic risk score) is indicative of suicidal/self-harm 
behaviors; and 3) whether genetic risk for BD interacts with traumatic event exposures to 
increase risk for suicidal/self-harm behaviors, independent of the presence of a mood disorder or 
substance use disorders.  
METHOD 
Participants 12-21 years old were ascertained from five independent sites, four in the 
United States (Johns Hopkins University, University of Michigan, Washington University in St. 
Louis, and Indiana University27) and one in Australia (University of New South Wales).28 All 
clinical procedures were approved by institutional review boards at the five centers. Written 
informed consent (or assent with parental consent for US participants <18 years old and 
Australian participants <17 years old) was obtained after a thorough explanation of the study. 
Participants were recruited using a “top-down” ascertainment method: that is, all offspring or 
other relatives in multiplex families of a proband with a confirmed DSM-IV diagnosis of bipolar 
disorder type-I (BP-I), type-II (BP-II), or schizoaffective disorder bipolar-type (SAB) who were 
in the age range 12-21 were eligible for inclusion, independent of the diagnostic status of the 
offspring. DSM-IV diagnosis was derived via the Diagnostic Interview for Genetic Studies 
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(DIGS)29 and the Family Instrument for Genetic Studies (FIGS).30 The BD-relatives were 
predominantly (88%) children of a proband with BD ascertained through the National Institute of 
Mental Health Genetics Initiative bipolar sample or similar genetic studies,31-33 only 6% were 
siblings of a proband with BD, and 6% were second-degree relatives of a proband from 
multiplex families where a first-degree relative with BP-I/SAB also existed. Control participants 
were in the same age range but had no first-degree relative with a DSM-IV diagnosis of BP-I or 
BP-II, SAB, recurrent major depression (MDD), schizophrenia, recurrent substance abuse, or any 
past psychiatric hospitalization; and no parent with a first-degree relative who had a past mood 
disorder hospitalization or history of psychosis. Controls were recruited via general medical 
clinics, motor vehicle records, print and electronic media, and notice boards in universities and 
local communities. BD-relatives came from 199 families, 116 with a single offspring, 60 with 2 
offspring, 16 with 3 offspring, 3 families with 4 offspring, and 1 family each with 5 and 6 
offspring. Controls were from 120 families: 86 with a single offspring, 24 with 2 offspring, 9 
with 3 offspring, and 1 family with 5 offspring. 
Data were collected between June 1, 2006 and September 30, 2012. In families of BD-
relatives and controls, all offspring were interviewed using the Kiddie Schedule for Affective 
Disorders (K-SADS)34 and provided a blood specimen for DNA analysis. At least one parent had 
to be available for interview; parents were interviewed about themselves (using the DIGS), about 
their spouse and other relatives (using the FIGS), and about all offspring (using the K-SADS, 
Parent Version [K-SADS-P]).  
Because existing versions of the K-SADS did not define specific episodes in time and 
duration before assessing symptoms and did not include questions targeting each DSM-IV 
criterion item for affective disorders, we adapted questions and interviewer instructions from the 
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DIGS to address these issues. The fully computerized K-SADS-BP is available at 
https://www.nimhgenetics.org/interviews/k-sads_bp_study55/index.php. Diagnoses were 
generated by best-estimate clinical consensus. Interviewers were extensively trained by the 
principal investigators and coordinators at each site after a weeklong common training at the 
Indiana University coordinating site. At each site, the interviewers or clinical coordinators had an 
extensive clinical background. Interviews were performed either in person or by telephone. The 
reliability of telephone interview for such purposes has been documented.35 Clinicians 
performing the best-estimate diagnoses were not blinded to the BD-relative/control status of the 
participant,36 but blind to the specific hypotheses of the study. Diagnoses and age at onset 
determinations were made on the basis of consensus between 2 clinicians (i.e., psychiatrists, 
clinical psychologists, or clinical social workers), including information from direct interview, 
medical records, and parent interview. Lifetime diagnoses were assigned according to DSM-IV 
criteria, including BP-NOS, which was generally diagnosed only if the participant approached 
the criteria for BP-II but had one fewer symptom in the hypomanic and depressive categories.  
Measures 
Dependent Variables. Lifetime occurrence of ideation, attempts, and NSSI were each studied 
independently over the course of follow-up, using data from all available K-SADS diagnostic 
assessments. NSSI is defined herein as the direct and deliberate infliction of pain or tissue 
damage without suicidal intent.37 Most lifetime ideation, attempts, and NSSI were reported at 
baseline at a mean age of 17 years. From baseline to the end of follow-up, there were 17 
additional incident reports of ideation, 7 incident reports of attempts, and 10 incident reports of 
NSSI.  
Independent Variables, Psychiatric Diagnoses. Lifetime DSM-IV mood disorders (major 
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depression, bipolar disorder) and a variable including lifetime DSM-IV substance use disorder 
(i.e., alcohol abuse or dependence and drug abuse or dependence) were computed utilizing best- 
estimate diagnoses from the K-SADS.  
Independent Variables, Traumatic Events. Traumatic event exposures were assessed 
through the Stressful Life Events Schedule child-reported (SLES-C) version,38 which assesses 
the presence of over 80 possible stressors in the past 12 months. Three SLES variables were 
utilized to tap exposure to bullying, domestic violence, and sexual abuse – each known risk 
factors or correlates of ideation and attempt. Endorsement of any of the three SLES traumatic 
event exposures were computed into a fourth composite variable, named “any trauma history.” 
Genotyping and Quality Control. Peripheral blood samples were collected from all 
individuals for genetic analysis. DNA was extracted from whole blood by the Rutgers University 
Cell and DNA Repository (US participants) or Genetic Repositories Australia (Australian 
participants), as previously described.39 Genome-wide SNP genotyping was conducted using the 
Infinium PsychArray BeadChip (Illumina, Scoresby, Victoria, Australia) at Mt. Sinai School of 
Medicine Genomics Core Facility, with genotype calling and quality control conducted using 
standard Psychiatric Genomics Consortium (PGC) pipelines. In brief, genotypes were called 
from three algorithms (birdseed, zCall, genCall) and SNPs with Hardy-Weinberg Equilibrium 
(HWE) p<1e-06 or genotype call rates < 97% removed, then resulting files merged in PLINK.40 
A second quality control was then applied to remove individuals with SNP call rates <98%, 
individuals with inbreeding coefficient FHET outside ±0.2 or genotype-derived sex discrepancy 
with recorded sex from clinical files. SNPs with minor allele frequency (MAF) <0.00001, and 
those with HWE p<1e-06 in controls or HWE p<1e-10 in cases were excluded, leaving 426,091 
SNPs. The successfully genotyped SNPs had a >99.6% genotype pass rate. 
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Imputation and multidimensional scaling analysis to develop genotype-derived ethnicity 
principal components was conducted following the ENIGMA2 protocols 
(http://enigma.ini.usc.edu/). Briefly, post-QC genotype files were merged with genotypes from 
ethnically diverse 1000 genomes samples (Human Mapping Set, phase 1 release v3), using SNPs 
that are polymorphic in European populations. SNPs with MAF <0.01, genotype call rate <95%, 
strand ambiguity, and those with HWE p<1e-06 were excluded prior to haplotype phasing and 
imputation using mach and minimach.41,42  
Multidimensional scaling analysis was conducted in PLINK using 164,680 independent 
SNPs across the panel, from which principal components were calculated. The principal 
components values from our sample were compared to those of participants of known ancestry to 
derive a genotype-derived ancestry allocation for each participant. Identity-by-descent (IBD) 
estimates were generated from 75,182 independent SNPs and were used to confirm documented 
familial relationships, identify any spurious relationships between participants, and identify 
gender discrepancies between genotype-derived and documented gender, resulting in subject 
exclusion.  
Polygenic Risk Score (PRS) Determination. BD-associated SNPs were selected on the 
basis of prior evidence of genetic association from the PGC1-BD discovery sample.23 Polygenic 
risk scores (PRS) were computed from index-SNPs after clumping based on linkage 
disequilibrium, using the --score function in PLINK,40 and were weighted by the log odds ratio 
of the risk allele from the original discovery GWAS.23 Prior to computing BD-PRS, strand-
ambiguous SNPs, indels, and those with imputation r2<0.8 were excluded. BD-PRS was tested at 
three increasingly liberal p-value thresholds: the first representing SNPs whose discovery p-
value was less than .0001 (BD-PRSp<0.0001; n=97 SNPs), the second representing SNPs whose 
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discovery p value was less than .001 (BD-PRSp<0.001; n=97+440 SNPs), and the third 
representing SNPs whose discovery p value was less than .01 (BD-PRSp<0.01; n=3,011 SNPs; 
97+440+2,474 SNPs). Participants were dichotomized into a high or low BD-PRS category for 
statistical analysis, where high BD-PRS represents the top 2 quintiles and low BD-PRS 
represents the bottom 3 quintiles.  
Demographic Characteristics 
Age, sex, and ethnicity were determined at baseline interview. Self-reported ethnicity, 
using the 7 United States Census categories, was consistent with genotype-derived ethnicity 
(98.7% concordance). Based on genotype-derived ethnicity, participants were categorized as 
Caucasian, African, or Other. Caucasian and African groups were used as covariates in the 
analyses each compared to the other ethnic group. In order to explore whether our findings were 
subject to confounding by ethnicity, we conducted analyses in Caucasians only.  
Statistical Analyses 
Demographic and clinical characteristics were compared between BD-relatives (n=307) 
and controls (n=166), as well as those with and without suicidal ideation, attempts, and NSSI 
using generalized estimating equations (GEE) models43-44 implemented in R software 
(https://www.r-project.org/). GEE enables specifying a binomial distribution for the outcome, 
and an exchangeable clustering pattern within family to correct for non-independence of 
measurement between siblings. This modeling approach was also implemented to test whether a 
high BD-PRS is predictive of ideation, attempts, and NSSI and whether it interacts with 
traumatic event exposures, adjusting for BD-relative status, ethnicity, and the presence of DSM-
IV mood disorders and substance use disorders. Interactions between BD-PRS high/low category 
and trauma exposure were estimated for models with significant main effects. All models using 
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the BD-PRS included adjustment for the genetically-informed ethnicity variables.  
RESULTS  
The demographic and clinical characteristics of the BD-relative and control groups are 
described in Table 1. The BD-relative and control groups were gender balanced and were mainly 
of European ancestry (85% vs. 65% for BD-relative and control groups, p<.001). At the time of 
baseline interview, the mean age of BD-relatives was slightly younger than the control group 
(16.7 vs. 17.1 years, p=.029). As expected, BD-relatives were more likely to have a DSM-IV 
lifetime mood disorder (OR=1.4, 95% CI=1.2-1.6, p<.001) and lifetime substance use disorder 
(OR=1.2, 95% CI=1.1-1.3, p=.006).  
BD-relatives were 30% more likely to have ideation and attempts than controls (OR=1.3, 
95% CI=1.1-1.5, p<.001; and OR=1.3, 95% CI=1.1-1.5, p=.003; respectively) but were not more 
likely to have NSSI (OR=1.1, 95% CI=0.9-1.2, p=.192). There were no group differences 
between BD-relatives and controls in exposure to domestic violence, sexual abuse, being bullied, 
or a composite measure of any traumatic event exposure.  
After adjusting for offspring mood and substance use disorders and demographic factors 
in the full sample, ideation and attempts were both significantly more prevalent in BD-relatives 
(OR=1.1, 95% CI=1.0-1.1, p=.012; and OR=1.1, 95% CI=1.0-1.2, p=.011), as compared to 
controls (Table 2). NSSI did not differ between BD-relatives and controls. In the sample of 
Caucasian-only participants, ideation and attempts were more common in BD-relatives than 
controls after adjusting for demographic variables (model 2), but did not remain significant after 
adjusting for offspring mood and substance use disorders (data not shown).  
Table 3 shows results of GEE analyses comparing those with and without ideation, 
attempts, and NSSI. Those with and without ideation, attempts, and NSSI did not differ 
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according to sex or baseline age. Caucasian participants were less likely to report ideation, 
attempts, and NSSI. Those with ideation were more likely to a have a mood disorder than those 
without (OR=17.7, 95% CI=8.3-37.7, p<.001), as were attempters versus non-attempters 
(OR=12.1, 95% CI=4.1-35.3, p<.001), and those with NSSI versus those without NSSI 
(OR=20.5, 95% CI=9.3-45.2; p<.001). Those with ideation were more likely than those without 
ideation to have a substance use disorder (OR=3.0, 95% CI=1.7-5.3, p<.001), as were attempters 
versus non-attempters (OR=4.9, 95% CI=2.2-10.8, p<.001), and those with NSSI versus those 
without NSSI (OR=2.8, 95% CI=1.5-5.0, p<.001). The only trauma history construct that was 
associated with any of the three suicide behavior outcomes was that any trauma history was two-
fold higher in suicide attempters than in non-attempters (OR=2.1, 95% CI=1.2-3.8, p=.014).  
Using the SNPs most robustly associated with BD from the PGC, we conducted analyses 
to determine whether a BD-PRS was higher in those with suicidal/self-harm behaviors compared 
to those with no suicidal/self-harm behaviors. Among participants of all ethnic backgrounds, BD-
relatives were more likely to have a higher BD-PRS than controls at the p <.001 and p<.01 
thresholds (BD-PRSp<0.001 OR=1.1, 95% CI=1.0- 1.2, p=.030; and BD-PRSp<0.01 OR=1.2, 95% 
CI=1.1-1.3, p=.001), after adjusting for age, sex, principal component analysis (PCA) ethnicity, 
mood and substance use disorders (Table 4). Those with higher BD-PRS at p<.01 were 
marginally more likely to have attempted suicide, after adjusting for BD-relative/control group, 
age, sex, PCA ethnicity and mood and substance use disorders (OR=2.3, 95% CI=1.0-5.4, 
p=.061). However, the mean BD-PRS did not differ between those with and without ideation or 
NSSI at any p-value threshold.  
Because the PGC discovery cohort was largely ethnically Caucasian, computation of BD-
PRS for ethnically diverse participants may result in distortion of the PRS due to ethnically 
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heterogeneous odds ratios and allele frequencies. Therefore, we repeated all BD-PRS analyses in 
Caucasian-only participants, representing around 80% of the full sample. BD-relatives were 
again more likely to have a higher BD-PRS than controls at p <.001 and p<.01 (OR=1.2, 95% 
CI=1.0-1.4, p=.035; and OR=1.2, 95% CI=1.0-1.5, p=.039; respectively) after adjusting for BD-
relative/control group, age, sex, ethnicity, mood and substance use disorders. However, among 
the smaller Caucasian-only sample (80% of the sample), odds ratios were not statistically 
significant for ideation, attempts, and NSSI (Table 4).  
To evaluate interactions of BD-PRS with trauma on the risk for suicide outcomes and 
relative status, we chose a single p-value discovery threshold of p<.001. Interestingly, for those 
participants who experienced trauma exposure and had a high BD-PRSp<.001, the risk for suicide 
attempt was significantly elevated after adjusting for sex, baseline age, BD-relative/control 
group, ethnicity, lifetime DSM-IV mood disorders and substance use disorders (OR=3.2, 95% 
CI=1.1-9.4, p=.037) (Table 5). Stronger effects were observed in the Caucasian-only analysis 
(OR=5.4, 95% CI=1.5-20.0, p=.011, data not shown) adjusting for demographic characteristics, 
mood disorders, and substance use disorders. 
DISCUSSION 
This study uniquely examines suicidal and self-harm behaviors in a young cohort of 
individuals who are at increased risk of BD, but many of whom have not yet developed BD 
themselves. We found that offspring of BD-relatives report more suicidal ideation and attempts 
than controls. This finding was sustained after adjusting for the presence of mood disorders and 
substance use disorders, suggesting that parental BD is a key correlate of suicidal ideation and 
attempts, and that genetic risk for suicidal behavior is not wholly acting through a genetic 
pathway for mood disorder. Importantly, we find that a high BD-PRS plus traumatic event 
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exposure is associated with increased suicide attempts, independent of mood or substance use 
disorders and ethnicity. This could imply that trauma exposure increases the risk of attempts 
especially among those at genetic risk, regardless of presence of mood disorders.  
To our knowledge, no prior studies have examined the relationship between BD-PRS and 
suicide attempt, let alone an interaction with traumatic events. The most permissive BD-PRS 
(derived from SNPs at p <.01) marginally differentiated those with and without attempts, 
independent of relatives status, PCA ethnicity, and mood and substance use disorders, whereas 
the more restrictive PRS did not. This may indicate that other genetically mediated aspects 
common to both BD and suicide behavior could be contributing, such as impulsivity, aggression, 
or severity of social, cognitive, or psychiatric impairment. Indeed, these pleiotropic effects may 
be more apparent in PRS derived from a larger number of variants, which will more likely 
encompass risk variants for BD as well as impulsive traits. The lack of association in the 
Caucasian-only analysis may indicate that population stratification is driving the association with 
suicide attempt in the larger more ethnically diverse sample, or that it is influenced by the loss of 
sample size, resulting in reduced power to detect significant differences. As the effect sizes in the 
Caucasian-only analysis are similar, the smaller sample size appears to be influencing those 
results, thus replication in a larger ethnically homogeneous cohort are warranted. Identification 
of specific genes influencing suicide attempt and exploration of genetic pleiotropy between BD 
and suicide attempt will soon be possible, pending the large-scale genome-wide association 
analysis of suicide attempt currently underway as part of the Psychiatric Genomics Consortium. 
There is a dearth of information on the link between NSSI and BD, although it has been 
reported that the risk factors for NSSI are similar to those for suicide attempts in young 
people.45,46 Intent to die is not evident in NSSI, and the motives behind NSSI and suicide 
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attempts differ.47 Small clinical studies have found an increase in NSSI among those with BD,48-
49 yet a recent meta-analysis on risk factors for NSSI did not find an association between NSSI 
and BD.50 NSSI had some different correlates than suicidal ideation and attempts in our study, as 
NSSI was associated with sex and age at interview, but not trauma exposure. Unlike suicidal 
ideation and attempts, NSSI was not significantly higher in BD-relatives than controls in the 
univariate model.  
We should acknowledge the limitations of the present observations. First, even in a high-
risk study, suicide attempts and exposures to trauma were relatively uncommon in our sample, 
thus a composite trauma exposure was used. Second, the assessment of childhood diagnoses rests 
on a combination of retrospective data from child and parental observations, supplemented with 
medical records when available. Third, we applied a genetic model that assumes additivity of 
risk alleles in a single aggregate score as per the methods used by the PGC.22 Fourth, 
measurement of trauma/stress (SLES) was over the 12 months prior to the baseline assessment, 
whereas the occurrence of SA, SI, and NSSI is a lifetime evaluation. The counterbalancing 
strengths are that this study includes well-characterized, at-risk youth from a genetically 
informative sample.  
Schaffer et al.,6 as part of the International Society for Bipolar Disorders Task Force on 
Suicide meta-analysis, notes the importance of integrating genetic, epigenetic, and social 
learning mechanisms when building models of psychobiological contributors to suicidal 
behaviors in BD. Early-life adversity and epigenetic mechanisms seem to be related to causal 
mechanisms for this diathesis. SKA2 DNA methylation mediates HPA-axis responsivity in the 
context of childhood trauma51 and has been associated with a range of HPA-axis related 
psychopathology including posttraumatic stress disorder52 and suicidal behavior.51,53 Biomarkers 
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might help to inform risk-assessment procedures and treatment choice for the prevention of 
suicide. 
Clinical Guidance: 
• We found that offspring of individuals with BD are at risk for suicidal attempts and 
ideation, but not only through specific mechanisms associated with mood disorder 
vulnerability.  
• We also found that genetic susceptibility to BD can increase the risk for suicide attempt, 
but only among those who also have experienced trauma.  
• This work highlights the importance of severe environmental stressors in the 
development of suicide attempts in those at risk for bipolar disorder. 
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Table 1. Demographic and Clinical Characteristics of the Sample 
 BD-Relatives 
n=307 
Controls 
n=166 
 
(OR) 
95% CI  
p Value 
 # % # %    
Demographics        
Female 152 50% 79 48% 0.9 0.9-1.1 .929 
Caucasian 261 85% 108 65% 2.8 1.5-5.3 .001 
Age at baseline 16.7 sd=3.0 17.1 sd=2.7 0.9 0.9-0.9 .029 
Axis I diagnoses        
Mood disorder 152 50% 36 22% 1.4 1.2-1.6 <.001 
Substance disorder 91 30% 29 17% 1.2 1.1-1.3 .006 
Conduct disorder 13 5% 1 0.01% 1.4 1.3-1.8 .0156 
ADHD 17 6.5% 4 03% 1.1 0.95-1.3 .191 
Self-injurious thoughts/behaviors 
Ideation 72 23% 15 9% 1.3 1.1-1.5 <.001 
Attempt 34  11% 6 4% 1.3 1.1-1.5 .003 
NSSI 55 18% 22 13% 1.1 0.9-1.2 .192 
Trauma history         
Domestic violence  24 8% 5 3% 0.9 0.8-1.0 .217 
Sexual abuse 12 4% 4 2% 0.9 0.8-1.0 .176 
Bullied 45 15% 15 9% 0.9 0.9-1.0 .324 
Any trauma history  69 22% 23 14% 1.0 0.9-1.1 .657 
Note: Statistics include no covariates. Bold text indicates statistical significance at p<.05. ADHD 
= attention-deficit/hyperactivity disorder; NSSI = nonsuicidal self-injury. 
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Table 2. Unadjusted and Adjusted Generalized Estimating Equations Analyses of Relative Status 
on Lifetime Ideation, Attempt, and Non-Suicidal Self-Injury (NSSI) 
 Model 1 Model 2 Model 3 
 OR 95% CI p Value OR 95% CI p Value OR 95% CI p Value 
All Participants          
ideation 1.3 1.1-1.5 <.001 1.2 1.1-1.3 <.001 1.1 1.0-1.1 .012 
attempts 1.3 1.1-1.5 .003 1.3 1.1-1.6 <.001  1.1 1.0-1.2 .011 
NSSI 1.1 0.9-1.2 .192 1.1 1.0-1.2 .016 1.0 0.9-1.1 .173 
Note: Results in boldface are statistically significant. Model 1: Unadjusted. 307 individuals with 
bipolar disorder (BD) relatives out of 473 individuals. Model 2: Adjusted for demographics (age, 
sex, and ethnicity). 286 individuals with relatives with BD out of 432 individuals. Model 3: 
Adjusted for demographics, mood disorders, and substance use disorders. 283 individuals with 
relatives with BD out of 422 individuals. 
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Table 3. Characteristics of Those With Ideation, Attempt, and Non-Suicidal Self-Injury (NSSI) 
 Ideation 
n=87 versus 336 with no ideation, 
attempt or NSSI  
Attempt 
n=40 versus 336 with no ideation, 
attempt or NSSI 
NSSI 
n=77 versus 336 with no ideation, 
attempt or NSSI 
  OR 95% CI p  OR 95% CI p  OR 95% CI p 
Demographics 
Female  0.9 0.5-1.7 .775  0.9 0.4-1.9 .729  1.3 0.7-2.5 .392 
Caucasian  0.3 0.1-0.9 .029  0.1  0.2-0.4 .001  0.3 0.1-0.9 .040 
Age at baseline  1.0 0.9-1.1 .918  1.0 0.8-1.1 .515  1.1 0.9-1.2 .105 
Axis I Diagnoses 
Mood disorder  17.7 8.3-37.7 <.001  12.1 4.1-35.3 <.001  20.5 9.3-45.2 <.001 
Substance use disorder  3.0 1.7-5.3 <.001  4.9 2.2-10.8 <.001  2.8 1.5-5.0 <.001 
Traumatic stress history  
Domestic violence  0.9 0.6-1.4 .550  1.3 0.7-2.4 .379  0.9 0.5-1.3 .408 
Sexual abuse  0.9 0.5-1.4 .597  1.5 0.8-2.8 .163  0.9 0.6-1.4 .642 
Bullied  1.2 0.8-1.8 .394  1.4 0.8-2.6 .231  0.9 0.6-1.4 .701 
Any trauma history  1.3 0.8-2.0 .252 
 2.1 1.2-3.8 .014  0.9 0.6-1.4   .743 
 
Note: Results in boldface are statistically significant. Generalized estimating equations analyses adjusted by demographics, mood and 
substance use disorders, and past-year traumatic stress history.  
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Table 4. Bipolar Disorder Polygenic Risk Score Associations 
 p-value threshold <.0001 p-value threshold <.001 p-value threshold <.01 
 OR 95% CI P value OR 95% CI P value OR 95% CI P value 
All (n/N)          
Ideation (79/386) 1.0 0.5-1.8 .914 0.9 0.5-1.6 .720 1.3 0.7-2.4 .367 
Attempt (35/342) 0.5 0.2-1-3 .169 1.2 0.5-2.6 .669 2.3 1.0-5.4 .061 
NSSI (75/382) 1.0 0.5-1.9 .943 1.1 0.6-2.0 .788 1.3 0.7-2.5 .420 
Relative Status 
(283/431) 
1.0 0.9-1.1 .275 1.1 1.0-1.2 .030 1.2 1.1-1.3 .001 
Caucasian          
Ideation (68/328) 1.1 0.6-2.2 .745 0.9 0.5-1.6 .671 1.1 0.6-2.1 .714 
Attempt (26/286) 0.6 0.2-1.8 .388 1.1 0.5-2.6 .787 1.5 0.6-3.4 .354 
NSSI (59/319) 1.1 0.5-2.3 .775 1.0 0.5-2.0 .932 1.1 0.6-2.1 .775 
Relative Status 
(255/362) 
1.0  0.9-1.2 .755 1.2 1.0-1.4 .035 1.2 1.0-1.5 .039 
Note: Results in boldface are statistically significant. Models for suicide/non-suicidal self-injury (NSSI) outcomes adjusted for sex, 
age, ethnicity, mood disorders, substance use disorders, and relative status.  
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Note: Results in boldface are statistically significant. Bipolar disorder-polygenic risk score (BD-PRS) p-value threshold is .001. NSSI 
= nonsuicidal self-injury. 
a
 Adjusted for demographics, and mood disorders and substance use disorders  
b
 Adjusted for demographics, BD-relatives status, and mood and substance use disorders 
c
 Interaction p-value is computed using the full sample and reflects the increased risk in the outcome for those with both trauma and 
high BD-PRS compared to those with no trauma and low BD-PRS.  
Table 5. Results of Polygenic Risk Score by Trauma Exposure Interaction  
 
No Trauma Trauma 
 
 OR 95% CI  P value OR 95% CI P value Interaction P value c 
Relatives a 
 
       
With Low PRS: (191/296) 
  
1.1 1.0-1.3 .066     
With High PRS: (92/135) 
   1.3 0.9,1.7 .125 .545 
Ideation b         
With Low PRS: (40/266) 0.78 0.3-1.3 .553     
With High PRS: (39/120) 
   1.1 0.4,1.2 .844 .348 
Attempt b 
 
   
    
With Low PRS: (12/238) 
   
0.27 0.05,1.4 .111 
    
With High PRS: (23/104) 
   2.7 0.9, 8.3 .089 .041 
NSSI b 
 
       
With Low PRS: (48/274) 
   
0.80 0.4, 1.8 .574     
With High PRS: (27/108) 
   1.1 0.3, 3.9 .883 .220 
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